Form D · Hedge Fund
BlackRock Health Sciences Access Ltd.
New York, NY · CIK 0001466799
Offering snapshot reported Feb 5, 2015 · SEC filing
- Reported sold
- $28.4M Indefinite offering
- Investors reported
- 127 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Feb 1, 2009 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 5, 2015 | Amendment | $28,390,597 | $0vs Feb 3, 2014 | 127 | SEC filing |
| Feb 3, 2014 | Amendment | $28,390,597 | $199,263vs Jun 28, 2012 | 127 | SEC filing |
| Jun 28, 2012 | Amendment | $28,191,334 | $169,400vs Jun 28, 2011 | 126 | SEC filing |
| Jun 28, 2011 | Amendment | $28,021,934 | $1,173,172vs Jun 23, 2010 | 125 | SEC filing |
| Jun 23, 2010 | Amendment | $26,848,762 | $16,523,457vs Jun 23, 2009 | 120 | SEC filing |
| Jun 23, 2009 | Initial | $10,325,305 | No comparison | 53 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $710K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-132189
Estimated maximum aggregate sales commission to be paid to the selling agent. The Sales commission to be deducted from the subscription amount varies from 0% to 2.50% based on the investor's cumulative investment in the entire HedgeAccess Program.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | 7691 |
Source: Form D, filed Feb 5, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Louis Costabile | Director, Executive |
| Justin Ferri | Director, Executive |
| Keith D. Glenfield | Director, Executive |
| Thomas Lee | Director, Executive |
| N/A Merrill Lynch Alternative Investments Llc | Promoter |
| N/A Merrill Lynch Alternative Investments Llc ("Mlai") | Executive |
| Deann D Morgan | Director, Executive |
| Paul Morton | Director, Executive |
| Colleen Rose Rusch | Director, Executive |
| Steven Lawrence Suss | Director, Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:New York, NY, 10080